Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Funding Year 2017 Epidemiology and Laboratory Capacity (ELC) HAI/AR Funded Activities

Many of these activities complement other CDC AR investments, collectively known as CDC’s AR Solutions Initiative, to fight antibiotic resistance across healthcare, community, and food in all 50 states, six large cities, and Puerto Rico.

  • Rapid Response, Containment, and Prevention Capacity– Coordination and implementation of HAI/AR prevention activities across the state/city/territory, managing the program’s advisory group, and implementing and reporting on progress of the HAI/AR plan. Activities focus on promoting proven prevention practices, detecting and responding to HAI/AR outbreaks, and increasing the use of National Healthcare Safety Network (NHSN) to track and prevent transmission of HAIs and AR pathogens in healthcare settings.
  • Rapid Detection of AR Pathogens through Enhanced State HAI/AR Laboratory Capacity, Coordination and Outreach – As part of AR Lab Network activities, all state public health laboratories and five major cities/territories receive support and lab capacity to detect, confirm, and characterize AR pathogens and novel resistance mechanisms. This will improve response to outbreaks and containment of AR threats in healthcare such as CRE, carbapenem-resistant Pseudomonas aeruginosa (CRPA), and C. auris.
  • Educational Efforts to Promote Appropriate Antibiotic Use – Assists state and local-level agencies in implementing health communication programs and behavioral interventions to promote appropriate antibiotic use. These programs aim to improve the knowledge, attitudes and behaviors of the general public and health care providers, contributing to a reduction in inappropriate prescribing and antibiotic resistance.
  • Coordinated Prevention and Stewardship – Support for state and local health departments to improve tracking of antibiotic use and resistance and expanding coordinated prevention and stewardship activities within HAI/AR prevention programs (beyond that described in the Infrastructure section above).
  • External Data Validation – Build and sustain health department programs’ ability to ensure the quality of healthcare-associated infection data reported to the National Healthcare Safety Network (NHSN).
  • Hemodialysis Bloodstream Infection (BSI) – Improve infection control practices and reduce infections in outpatient hemodialysis centers.
  • Injection Safety – Drive implementation of safe injection practices among healthcare providers through education, training, and other means. The CDC-led Safe Injection Practices Coalition (SIPC) collaborates with health departments and other partners to achieve this goal.
  • Antibiotic Resistance Laboratory Network (AR Lab Network) – Support the AR Lab Network to track changes in resistance and help identify and respond to outbreaks faster. The AR Lab Network includes seven regional labs, the National Tuberculosis Molecular Surveillance Center (National TB Center), and labs in 50 states, five cities, and Puerto Rico. It supports nationwide lab capacity to rapidly detect antibiotic resistance in healthcare, food, and the community, and inform local responses to prevent spread and protect people. The AR Lab Network is capable of detecting known and emerging resistance threats, such as increased testing nationwide for the fungal threat Candida, including the emerging drug-resistant C. auris. The AR Lab Network also identifies germs that could be used to support researchers in developing new diagnostics and more treatment options through the CDC AR Isolate Bank. Learn more about the AR Lab Network and AR investments in your state.

Learn more about HAI prevention activities in your state.

TOP